Robert Morreale/Visual Explanations, LLC © 2005-2011 American Society of Clinical Oncology (ASCO)
Canadian Agency’s Outlook on Ovarian Ablation Endorsed
In keeping with its policy of endorsing guidelines developed by other organizations deemed appropriate, an American Society of Clinical Oncology (ASCO) ad hoc panel has voiced agreement with clinical guidelines established by Cancer Care Ontario (CCO) on adjuvant ovarian ablation (OA) for premenopausal women with earlystage invasive breast cancer. Lung Cancer
Chemotherapy Limits for Stage IV Patients Weighed
An ASCO update committee recommended that patients with stage IV non-small cell lung cancer who have received 4 cycles of first-line chemotherapy and whose disease has not progressed could be immediately switched to alternative, single-agent chemotherapy to extend progression-free survival and, potentially, overall survival. Supportive Care
Review of Antiemetic Therapies Yields New Recommendations
In its first review of antiemetic therapies since 2006, an ASCO committee tackled key clinical questions involving chemotherapyinduced and radiation-induced nausea and vomiting, clarifying language and refining guidelines in several areas.
... to read the full story